Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-035558
Filing Date
2019-06-07
Accepted
2019-06-07 16:35:04
Documents
2
Period of Report
2019-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3740
2 EX-24 DOCUMENT attachment1.htm EX-24 2128
  Complete submission text file 0001209191-19-035558.txt   7436
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Issuer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NANTKWEST, INC. 2533 SOUTH COAST HIGHWAY 101, SUITE 210 CARDIFF-BY-THE-SEA CA 92007
Business Address
BLASZYK MICHAEL D (Reporting) CIK: 0001371407 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37507 | Film No.: 19886132